Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial. - Wikidata - awgldk - TriplyDB

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.

http://www.wikidata.org/entity/Q43059658

about

Pharmacological treatment for memory disorder in multiple sclerosis Pharmacologic treatment for memory disorder in multiple sclerosis Cognitive impairment in multiple sclerosis Treatment of cognitive impairment in patients with multiple sclerosis Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosis.Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis Cognitive dysfunction in multiple sclerosis.New approaches in the management of multiple sclerosis.Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review.Therapeutics for multiple sclerosis symptoms.Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training.Treatment of cognitive impairment in multiple sclerosis: position paper.Neuroprotection in multiple sclerosis: a therapeutic approach.Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.Modulating inflammation and neuroprotection in multiple sclerosis.Biological outcome measurements for behavioral interventions in multiple sclerosis.Survey-based assessment of the relationship between cognitive impairment and mentally stimulating activity in multiple sclerosis.Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis.The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.Enhancing the quality of care for patients with multiple sclerosis through performance improvement CME.Autobiographical memory in multiple sclerosis patients: assessment and cognitive facilitation.Cognitive impairment and MS: searching for effective therapies.Effects of memantine treatment on language abilities and functional communication: A review of data

P2860

Q24201735-2B111528-E3A8-4A4C-9129-D6D68A6BC977 Q24236019-57DE8CE9-B0C5-42A0-B24E-C5E68723DE3F Q28270988-07B4305A-879C-4E25-9D64-A0CF15D29FF0 Q28272736-2C795AA6-73B5-4114-9477-3AF3D7524B61 Q30524879-8AB9525E-0568-41AD-9B66-B111576EE3E5 Q33598958-46986A9F-B9FF-4116-BC56-AF1F1F83EB7D Q34146191-7AD418B3-1CAD-4394-A808-E2D17BD30540 Q34288839-561392CB-AE4F-49F0-B717-8F718D64647A Q34389528-FBC9388C-1ED3-46FC-B6CF-E92AE2F1E5DD Q35377529-757F1244-9446-476F-9EA0-BEB8143FFDAC Q36045044-DD50E330-E0A0-4FB9-877C-A52C41A3F851 Q37855721-C7DD8EF2-9F01-4C7D-9004-869E1FCEE59C Q37891595-DD8F077F-5635-42E6-A508-145B1CC9AFC3 Q38062466-BCB07329-FD34-40E9-BB28-D2B9C537C754 Q38129748-C06AD7A2-68A1-441B-B70F-EABD50580B37 Q38639337-C3A756F6-C949-4C64-A225-00B6D6D4D4D0 Q38736551-E75FE467-E7C5-41E0-A9E4-A12F5C755320 Q39350409-0F0F5DF7-CBB0-4A3D-A566-C65B949565A0 Q42789516-F1989306-8449-4AE5-9F6F-9DFE59124C85 Q47836124-AC4B7DAC-7081-4331-9EFE-244926C80CF7 Q47978062-CDA3DD43-B985-4332-8B51-F15A2C24420F Q48337817-98443ED7-1FFE-40EF-9E67-DEEDBFBC8128 Q50236159-BE457336-A680-4A4D-99B8-9F59494F6ECA Q50743400-E98F496B-3D0D-450B-BCE1-8C2BCFFC8C83 Q51859117-41E9A681-B880-4EA1-B3EC-78D3215EF254 Q58135501-7A8ED74F-F904-42FE-A8D7-89A5438CE45D

P2860

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.

http://www.wikidata.org/entity/Q43059658

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Memantine for cognitive impair ...... ized placebo-controlled trial.

@en

Memantine for cognitive impair ...... ized placebo-controlled trial.

@nl

type

label

Memantine for cognitive impair ...... ized placebo-controlled trial.

@en

Memantine for cognitive impair ...... ized placebo-controlled trial.

@nl

prefLabel

Memantine for cognitive impair ...... ized placebo-controlled trial.

@en

Memantine for cognitive impair ...... ized placebo-controlled trial.

@nl

P1433

Q43059658-DBB7CA52-322A-4B4C-94FE-CC6EBA50869D

P1476

Q43059658-C8C5AA23-3B14-40C1-8FD4-C833072591F3

P2093

Q43059658-137060A7-F1FF-48B2-8B59-DD68189F7465

Q43059658-14AB8861-25DB-4962-B94B-B869A384A93C

Q43059658-14D5A371-70F0-470B-BE84-CC4709528070

Q43059658-1554D79E-BC3B-43D3-AA52-4A8D605E174D

Q43059658-2F8843FF-CF25-47F9-8CD9-1A404B454973

Q43059658-3F1E3E62-AB33-47D1-BF47-9F811DFF1FF6

Q43059658-3F463B7C-E4B9-41E9-9D5C-048641136EB3

Q43059658-5C52FAD2-EE1A-451E-B4EA-E96481291E82

Q43059658-5C610E12-5B9F-4E66-84B7-F2E93996BBD2

Q43059658-5F23042F-2A00-4345-BE2D-D2652878A063

P2860

Q43059658-00449BA1-ED85-4C2E-9300-7FFA57461617

Q43059658-04B22586-697A-4F31-ABCC-86B628F978BA

Q43059658-196F9A54-098A-4BA4-BA0C-8B558E68ED79

Q43059658-1A509CA9-5226-4D04-BFE7-7D01AD8DE684

Q43059658-29006F37-B009-4DAD-A091-2B09B975537D

Q43059658-3F1A55DC-BAB2-4BF3-B597-E9DF475136FD

Q43059658-445FBD79-BA4F-4C3D-B4E5-67A9E41F84AD

Q43059658-5606A0B0-C5F3-4680-9BFA-22FA78127A69

Q43059658-5F132701-CB73-4064-A84B-81B6284EF39D

Q43059658-690FCD8C-5024-4971-8567-11BA5F5C3A90

P304

Q43059658-62E10E0E-486D-407F-A01D-1C8343CA7A57

P31

Q43059658-C2D8D5B5-A715-41A7-BE1A-221DD0512AB1

P356

Q43059658-A5967B05-2E46-42A9-859F-EA49E6AFFF42

P433

Q43059658-786707CC-49F3-4465-9C8A-2E3B513FA6FB

P478

Q43059658-09651895-9381-4B8E-BF6B-21BAB699B908

P577

Q43059658-5282E2F2-9DCF-4185-9221-649D4EE99F96

P698

Q43059658-0D0261AE-176C-4416-84FD-815C049BC273

P921

Q43059658-8E9936DB-F916-453F-8A75-05F9A456DE07

Q43059658-A9A9C5BA-70D1-4063-8AEB-66F7CB3F35CF

P356

1352458510367662

P1433

Multiple Sclerosis Journal

P1476

Memantine for cognitive impair ...... ized placebo-controlled trial.

@en

P2093

D Bandari

http://www.w3.org/2001/XMLSchema#string

D Bourdette

http://www.w3.org/2001/XMLSchema#string

E Frohman

http://www.w3.org/2001/XMLSchema#string

G Heimburger

http://www.w3.org/2001/XMLSchema#string

G Remingon

http://www.w3.org/2001/XMLSchema#string

J F Lovera

http://www.w3.org/2001/XMLSchema#string

J Fowler

http://www.w3.org/2001/XMLSchema#string

J Karman

http://www.w3.org/2001/XMLSchema#string

J McAleenan

http://www.w3.org/2001/XMLSchema#string

K Bogardus

http://www.w3.org/2001/XMLSchema#string

P2860

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis

Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial.

Memantine induces reversible neurologic impairment in patients with MS.

Minimal neuropsychological assessment of MS patients: a consensus approach.

Neuropsychology of multiple sclerosis: a critical review.

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage.

Memantine in moderate-to-severe Alzheimer's disease.

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

P304

715-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458510367662

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20483885

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis